Publisher
Springer International Publishing
Reference34 articles.
1. Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(S6):1–158. Special Issue: WFH Guidelines for the Management of Hemophilia, 3rd edition
2. Eckhardt CL, Loomans JI, van Velzen AS, et al. Inhibitor development and mortality in non- severe hemophilia A. J Thromb Haemost. 2015;13:1217–25.
3. Brackmann HH, Gormsen J. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder. Lancet. 1977;2(8044):933.
4. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitors--twenty years’ ‘bonn protocol’. Vox Sang. 1996;70(Suppl 1):30–5.
5. Mauser-Bunschoten EP, Nieuwenhuis HK, Roosendaal G, van den Berg HM. Low-dose immune tolerance induction in hemophilia A patients with inhibitors. Blood. 1995;86:983–8.